Fundraising FoxLeucid
London, GB · 3 known investors
Find your way into Leucid
Sign up to find every way you can get introduced to Leucid
- Your email: who you already know at Leucid, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Leucid team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Leucid Bio develops CAR-T cell therapies based on a proprietary Lateral CAR platform that redesigns the CAR structure to mimic the lateral signalling arrangement of natural immune receptors. The technology, derived from 20 years of research led by Dr John Maher at King's College London, aims to increase T-cell potency and durability while reducing toxicity.
Founders & leadership
JM
John MaherFounder
Investors · 3
Related companies · 2
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Kite PharmaKite develops CAR T-cell therapies that engineer a patient's own immune cells to target and destroy cancer cells. The company focuses on cell therapy treatments for cancers such as diffuse large B-cell lymphoma.
Companies working in the same space as Leucid.
Frequently asked questions
- What does Leucid do?
- Leucid Bio develops CAR-T cell therapies based on a proprietary Lateral CAR platform that redesigns the CAR structure to mimic the lateral signalling arrangement of natural immune receptors. The technology, derived from 20 years of research led by Dr John Maher at King's College London, aims to increase T-cell potency and durability while reducing toxicity.
- Who founded Leucid?
- Leucid was founded by John Maher.
- Who are Leucid's investors?
- Leucid's investors include Sofinnova Partners, Vulpes Investment Management, Epidarex Capital.
- Where is Leucid headquartered?
- Leucid is headquartered in London, GB.